Compound information
- Natural Products
- ZC373793
- Molecular Formula
- C14H20N2O4S
- Molecular Weight
- 312.11437812 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(p-tolylsulfonyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C14H20N2O4S/c1-3-20-14(17)15-8-10-16(11-9-15)21(18,19)13-6-4-12(2)5-7-13/h4-7H,3,8-11H2,1-2H3
- InChI Key
- QAANTRUGYDHFPN-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccc(C)cc2)CC1
- Source
- ZINC000000122636
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 2.066 |
LogS | -3.018 | LogD | 2.4 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.034 | Pgp substrate | 0.047 |
HIA | 0.98 | F20 % | 0.987 |
F30 % | 0.88 | Caco-2 | -4.326 |
MDCK | -4.793 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.731 | PPB | 85.579 |
VD | 1.009 | Fu | 0.831 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.049 | CYP1A2 substrate | 0.566 |
CYP2A6 substrate | 0.667 | CYP2B6 substrate | 0.67 |
CYP2C19 inhibitor | 0.807 | CYP2C19 substrate | 0.838 |
CYP2C8 substrate | 0.716 | CYP2C9 inhibitor | 0.813 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.817 | CYP2E1 substrate | 0.747 |
CYP3A4 inhibitor | 0.042 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.455 | CL | 5.426 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.402 | Hepatotoxicity | 0.606 |
Mutagenicity | 0.162 | Rat Oral Acute Toxicity | 0.186 |
FDAMDD | 0.092 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.747 | Eye Corrosion | 0.003 |
Eye Irritation | 0.058 | Respiratory Toxicity | 0.086 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.683 | IGC50 | 3.091 |
LC50FM | 2.712 | LC50DM | 0.801 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.299 | NR-AR-LBD | 0.352 |
NR-AhR | 0.059 | NR-Aromatase | 0.08 |
NR-ER | 0.271 | NR-ER-LBD | 0.371 |
NR-PPAR-gamma | 0.131 | SR-ARE | 0.371 |
SR-ATAD5 | 0.288 | SR-HSE | 0.076 |
SR-MMP | 0.012 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.